Proton Beam Therapy in Breast Cancer Patients: The UK PARABLE Trial is Recruiting.

Kirby, A M; Haviland, J S; Mackenzie, M; Fleming, H; Anandadas, C; Wickers, S; Miles, E; Iles, N; Bliss, J M; Coles, C E

Kirby, A M; Haviland, J S; Mackenzie, M; Fleming, H; Anandadas, C; Wickers, S; Miles, E; Iles, N; Bliss, J M; Coles, C E.

Afiliación

Kirby AM; The Institute of Cancer Research, London, UK; The Royal Marsden Hospital, Sutton, UK. Electronic address: anna.kirby@rmh.nhs.uk.
Haviland JS; The Institute of Cancer Research, London, UK; Wolfson Institute of Population Health, Queen Mary University of London, London, UK.
Mackenzie M; Independent Cancer Patients' Voice, UK.
Fleming H; NCRI CTRad Consumer Advocate, UK.
Anandadas C; Department of Clinical Oncology, The Christie Hospital NHS Foundation Trust, Manchester, UK.
Wickers S; Radiotherapy Department, University College London Hospital NHS Foundation Trust, London, UK.
Miles E; National Radiotherapy Trials Quality Assurance Group (RTTQA), Mount Vernon Hospital, Northwood, UK.
Iles N; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK.
Bliss JM; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK.
Coles CE; Department of Oncology, University of Cambridge, Cambridge, UK.

Clin Oncol (R Coll Radiol) ; 35(6): 347-350, 2023 06.

Article en En | MEDLINE | ID: mdl-36933970

Asunto(s)

Neoplasias de la Mama; Terapia de Protones; Humanos; Femenino; Neoplasias de la Mama/radioterapia; Dosificación Radioterapéutica; Reino Unido/epidemiología

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Terapia de Protones Límite: Female / Humans País/Región como asunto: Europa Idioma: En Revista: Clin Oncol (R Coll Radiol) Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google